| From NASH to HCC: current concepts and future challenges QM Anstee, HL Reeves, E Kotsiliti, O Govaere, M Heikenwalder Nature reviews Gastroenterology & hepatology 16 (7), 411-428, 2019 | 1087 | 2019 |
| Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease L Boulter, O Govaere, TG Bird, S Radulescu, P Ramachandran, ... Nature medicine 18 (4), 572-579, 2012 | 787 | 2012 |
| NASH limits anti-tumour surveillance in immunotherapy-treated HCC D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ... Nature 592 (7854), 450-456, 2021 | 764 | 2021 |
| Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis O Krenkel, T Puengel, O Govaere, AT Abdallah, JC Mossanen, ... Hepatology 67 (4), 1270-1283, 2018 | 460 | 2018 |
| Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes M Komuta, O Govaere, V Vandecaveye, J Akiba, W Van Steenbergen, ... Hepatology 55 (6), 1876-1888, 2012 | 369 | 2012 |
| Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ... Journal of hepatology 73 (3), 505-515, 2020 | 344 | 2020 |
| Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury JC Mossanen, O Krenkel, C Ergen, O Govaere, A Liepelt, T Puengel, ... Hepatology 64 (5), 1667-1682, 2016 | 313 | 2016 |
| Keratin 19: a key role player in the invasion of human hepatocellular carcinomas O Govaere, M Komuta, J Berkers, B Spee, C Janssen, F De Luca, ... Gut 63 (4), 674-685, 2014 | 273 | 2014 |
| Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis O Govaere, S Cockell, D Tiniakos, R Queen, R Younes, M Vacca, ... Science translational medicine 12 (572), eaba4448, 2020 | 219 | 2020 |
| TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence TG Bird, M Müller, L Boulter, DF Vincent, RA Ridgway, ... Science translational medicine 10 (454), eaan1230, 2018 | 206 | 2018 |
| FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis L Verbeke, I Mannaerts, R Schierwagen, O Govaere, S Klein, ... Scientific reports 6 (1), 1-12, 2016 | 201 | 2016 |
| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 196 | 2021 |
| Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis L Hammerich, JM Bangen, O Govaere, HW Zimmermann, N Gassler, ... Hepatology 59 (2), 630-642, 2014 | 192 | 2014 |
| Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching L De Smedt, S Palmans, D Andel, O Govaere, B Boeckx, D Smeets, ... British journal of cancer 116 (1), 58-65, 2017 | 159 | 2017 |
| Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma R Janky, MM Binda, J Allemeersch, A Van den Broeck, O Govaere, ... BMC cancer 16, 1-15, 2016 | 147 | 2016 |
| Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? R Younes, O Govaere, S Petta, L Miele, D Tiniakos, A Burt, E David, ... Gut 71 (2), 382-390, 2022 | 140 | 2022 |
| Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis L De Smedt, J Lemahieu, S Palmans, O Govaere, T Tousseyn, ... British journal of cancer 113 (3), 500-509, 2015 | 139 | 2015 |
| Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche O Govaere, J Wouters, M Petz, YP Vandewynckel, K Van den Eynde, ... Journal of hepatology 64 (3), 609-617, 2016 | 128 | 2016 |
| Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease R Younes, GP Caviglia, O Govaere, C Rosso, A Armandi, T Sanavia, ... Journal of hepatology 75 (4), 786-794, 2021 | 119 | 2021 |
| Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease M Boyle, D Tiniakos, JM Schattenberg, V Ratziu, E Bugianessi, S Petta, ... Jhep Reports 1 (3), 188-198, 2019 | 101 | 2019 |
